MCID: FML012
MIFTS: 54

Familial Partial Lipodystrophy malady

Genetic diseases category

Summaries for Familial Partial Lipodystrophy

About this section
Sources:
63Wikipedia, 46OMIM, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:63 Familial partial lipodystrophy (also known as \"Köbberling–Dunnigan syndrome\") is an autosomal... more...

MalaCards: Familial Partial Lipodystrophy, also known as familial partial lipodystrophy, type 2, is related to lipodystrophy and obesity. An important gene associated with Familial Partial Lipodystrophy is LMNA (lamin A/C), and among its related pathways are PPAR signaling pathway and Regulation of thyroid hormone activity. The compounds estrogen and cycloheximide have been mentioned in the context of this disorder. Affiliated tissues include skin, skeletal muscle and adipocyte, and related mouse phenotypes are skeleton and integument.

Description from OMIM:46 604367,151660

Aliases & Classifications for Familial Partial Lipodystrophy

About this section
Sources:
8Disease Ontology, 42NIH Rare Diseases, 22GTR, 60UMLS, 44Novoseek, 46OMIM, 34MeSH
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases


Aliases & Descriptions:

familial partial lipodystrophy 8 42 22 60
familial partial lipodystrophy, type 2 60
lipodystrophy, familial partial 44
koberling-dunnigan syndrome 8
dunnigan syndrome 8


External Ids:

Disease Ontology8 DOID:0050440
MeSH34 D052496

Related Diseases for Familial Partial Lipodystrophy

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Lipodystrophy, Familial Partial, Type 2 family:

familial partial lipodystrophy Familial Partial Lipodystrophy Type 3
Familial Partial Lipodystrophy Type 4 Lipodystrophy, Familial Partial, Type 5
Familial Partial Lipodystrophy Due to Akt2 Mutations

Diseases related to Familial Partial Lipodystrophy via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 141)
idRelated DiseaseScoreTop Affiliating Genes
1lipodystrophy31.5PPARG, AKT2, EMD, RETN, INS, LEP
2obesity30.3TNF, APOE, DIO2, PPARGC1A, PPARG, RBP4
3emery-dreifuss muscular dystrophy30.1EMD, LMNA
4muscular dystrophy30.1CAPN3, EMD, LMNA
5glomerulonephritis30.1RBP4
6acquired generalized lipodystrophy30.1RETN, LEP, ADIPOQ
7congenital generalized lipodystrophy type 230.1PPARG, INS, LEP, LMNA, ADIPOQ
8vascular disease30.1APOE, PPARG, RETN, INS, ADIPOQ
9familial hyperlipidemia30.1APOE, PPARGC1A, PPARG, RETN, INS, LEP
10atherosclerosis30.1TNF, APOE, PPARGC1A, PPARG, RBP4, RETN
11diabetes mellitus30.1TNF, APOE, PPARGC1A, PPARG, RBP4, AKT2
12lipodystrophy, familial partial, type 210.6
13familial partial lipodystrophy, kobberling type10.6
14familial partial lipodystrophy type 410.5
15familial partial lipodystrophy type 310.4
16insulin resistance, severe, digenic10.3
17lipodystrophy, familial partial, type 510.3
18familial partial lipodystrophy due to akt2 mutations10.3
19focal segmental glomerulosclerosis10.1
20eclampsia10.1
21familial hypertriglyceridemia10.1
22congenital generalized lipodystrophy10.1
23lipoatrophic diabetes10.1
24focal glomerulosclerosis10.1
25hepatitis10.1
26hyperaldosteronism10.1
27pre-eclampsia10.1
28skin disease10.1
29thyroiditis10.1
30vascular skin disease10.1
31werner syndrome10.0LMNA
32mandibuloacral dysplasia10.0LMNA
33goiter10.0DIO2
34diabetic retinopathy10.0INS
35graves' disease10.0DIO2
36acute myocardial infarction10.0RETN
37myositis10.0CAPN3
38thyrotoxicosis10.0INS
39acute pancreatitis10.0RETN
40pancreatitis10.0INS
41blindness10.0INS
42schizophrenia10.0INS
43cerebrovascular disease10.0APOE
44dilated cardiomyopathy10.0EMD, LMNA
45abdominal aortic aneurysm10.0APOE
46narcolepsy10.0LEP
47hypoglycemia10.0INS
48severe pre-eclampsia10.0LEP
49rabson-mendenhall syndrome10.0INS
50emery-dreifuss muscular dystrophy 2, ad10.0EMD, LMNA

Graphical network of the top 20 diseases related to Familial Partial Lipodystrophy:



Diseases related to familial partial lipodystrophy

Clinical Features for Familial Partial Lipodystrophy

About this section
Sources:
46OMIM
See all sources

Clinical features from OMIM:

604367,151660

Drugs & Therapeutics for Familial Partial Lipodystrophy

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Familial Partial Lipodystrophy

Drug clinical trials:

Search ClinicalTrials for Familial Partial Lipodystrophy

Search NIH Clinical Center for Familial Partial Lipodystrophy

Search CenterWatch for Familial Partial Lipodystrophy

Genetic Tests for Familial Partial Lipodystrophy

About this section
Sources:
22GTR
See all sources

Genetic tests related to Familial Partial Lipodystrophy:

id Genetic test Affiliating Genes
1 Familial Partial Lipodystrophy22

Anatomical Context for Familial Partial Lipodystrophy

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Familial Partial Lipodystrophy:

32
Skin, Skeletal muscle, Adipocyte, Thyroid, Breast

Animal Models for Familial Partial Lipodystrophy or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Familial Partial Lipodystrophy:

36 (show all 22)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000539010.2AKT2, LMNA
2MP:00107719.9INS, PLIN1, ADIPOQ
3MP:00053889.6RARB, AKT2
4MP:00020068.7PPARGC1A, PPARG, AKT2, LEP, ADIPOQ, TNF
5MP:00053898.7DIO3, RBP4, AKT2, RARB
6MP:00053798.7TNF, DIO1, PPARGC1A, RBP4, RARB
7MP:00030128.6CAPN3, TNF, APOE, PPARG, AKT2, INS
8MP:00053677.9APOE, DIO1, DIO2, PPARG, INS, LEP
9MP:00053817.8TNF, APOE, DIO1, DIO2, PPARGC1A, INS
10MP:00053917.7TNF, APOE, PPARG, RBP4, INS, LEP
11MP:00053757.5TNF, APOE, PPARGC1A, PPARG, AKT2, RETN
12MP:00053707.5TNF, APOE, PPARGC1A, PPARG, AKT2, RETN
13MP:00053977.3TNF, APOE, PPARG, AKT2, INS, LEP
14MP:00053867.3TNF, APOE, PPARGC1A, PPARG, EMD, INS
15MP:00053877.3TNF, APOE, PPARG, AKT2, INS, LEP
16MP:00036317.2TNF, APOE, PPARGC1A, PPARG, AKT2, INS
17MP:00053847.0PPARG, PPARGC1A, DIO3, APOE, TNF, RBP4
18MP:00053856.8CAPN3, TNF, APOE, PPARGC1A, PPARG, RBP4
19MP:00053696.4ADIPOQ, CAPN3, TNF, APOE, PPARGC1A, PPARG
20MP:00107686.3TNF, APOE, DIO3, PPARGC1A, PPARG, AKT2
21MP:00053786.1CAPN3, TNF, APOE, DIO1, DIO3, DIO2
22MP:00053765.6PPARGC1A, DIO2, DIO3, DIO1, APOE, TNF

Publications for Familial Partial Lipodystrophy

About this section
Sources:
50PubMed
See all sources

Articles related to Familial Partial Lipodystrophy:

(show top 50)    (show all 87)
idTitleAuthorsYear
1
Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety. (23783098)
2013
2
Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy-causing mutations. (23243001)
2013
3
Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA. (24080738)
2013
4
Quantitative whole-body MRI in familial partial lipodystrophy type 2: changes in adipose tissue distribution coincide with biochemical improvement. (23096204)
2012
5
Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations. (21883346)
2012
6
Body fat distribution in women with familial partial lipodystrophy caused by mutation in the lamin A/C gene. (22276265)
2012
7
Premature atherosclerosis in a Japanese diabetic patient with atypical familial partial lipodystrophy and hypertriglyceridemia. (22989829)
2012
8
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution. (22935701)
2012
9
Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARI^ mutation (Y151C). (21479595)
2011
10
Visual vignette. Type 2 familial partial lipodystrophy syndrome of the Dunnigan variety. (21454231)
2011
11
Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations. (20041886)
2010
12
Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family. (20625965)
2010
13
A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease. (19011997)
2009
14
Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD). (19574635)
2009
15
The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. (19201734)
2009
16
Obstructive sleep apnea in familial partial lipodystrophy type 2 with atypical skin findings and vascular disease. (19418082)
2009
17
Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. (18805829)
2009
18
Serum retinol binding protein 4 in patients with familial partial lipodystrophy. (19303000)
2009
19
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. (18364375)
2008
20
Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety. (19040647)
2008
21
Obstructive sleep apnea in 2 women with familial partial lipodystrophy due to a heterozygous LMNA R482Q mutation. (17893350)
2007
22
Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. (17524034)
2007
23
The retinol acid receptor B gene is hypermethylated in patients with familial partial lipodystrophy. (17556535)
2007
24
The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy. (18041775)
2007
25
Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy. (16732025)
2006
26
Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. (16415042)
2006
27
Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3). (16412238)
2006
28
An imaging study of body composition including lipodeposition pattern in a patient of familial partial lipodystrophy (Dunnigan type). (16459536)
2005
29
Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone. (16241930)
2005
30
Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. (16320084)
2005
31
Familial partial lipodystrophy complicated by pre-eclampsia. (15814388)
2005
32
Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. (16181372)
2005
33
Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome). (14988595)
2004
34
Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription. (14597414)
2003
35
Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. (12716787)
2003
36
KAPbberling type of familial partial lipodystrophy: an underrecognized syndrome. (12766116)
2003
37
Post-mortem findings in familial partial lipodystrophy, Dunnigan variety. (12647844)
2002
38
PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. (12453919)
2002
39
Clinical, endocrine and metabolic studies in the kindred of familial partial lipodystrophy--a syndrome of insulin resistance. (12240840)
2002
40
Consider cardiomyopathy in subjects with familial partial lipodystrophy. (11790714)
2002
41
Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene. (11231979)
2001
42
Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. (11344241)
2001
43
Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). (10843151)
2000
44
Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome. (11136544)
2000
45
Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan- type familial partial lipodystrophy. (10587585)
2000
46
Mutations of the lamin A/C gene causing familial partial lipodystrophy: significance for the development of hyperlipidemia and insulin resistant diabetes mellitus]. (10820868)
2000
47
Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). (9920078)
1999
48
Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. (9500556)
1998
49
Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis. (2385743)
1990
50
Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. (3712389)
1986

Genetic Variations for Familial Partial Lipodystrophy

About this section

Expression for genes affiliated with Familial Partial Lipodystrophy

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Familial Partial Lipodystrophy

Search GEO for disease gene expression data for Familial Partial Lipodystrophy.

Pathways for genes affiliated with Familial Partial Lipodystrophy

About this section
Sources:
29KEGG, 53Reactome, 37NCBI BioSystems Database, 12EMD Millipore, 49PharmGKB, 4Cell Signaling Technology, 52R&D Systems, 51QIAGEN
See all sources

Pathways related to Familial Partial Lipodystrophy according to GeneCards/GeneDecks:

(show all 18)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.8PPARG, PLIN1, ADIPOQ
2
Hide members
9.7DIO1, DIO3
3
Hide members
9.7PLIN1, LEP, INS
4
Hide members
9.7BANF1, EMD, LMNA
5
Hide members
9.7LMNA, EMD, BANF1
6
Apoptosis and survival Caspase cascade
Hide members
9.6TNF, AKT2, LMNA
79.6ADIPOQ, LEP, AKT2
8
Hide members
9.6INS, RBP4, PPARG
99.5DIO2, DIO3, DIO1
10
Hide members
9.5TNF, INS, ADIPOQ
11
Translation Insulin regulation of translation
Hide members
9.3INS, AKT2, PPARGC1A, TNF
129.2PPARGC1A, PPARG, LEP, PLIN1, ADIPOQ
138.9TNF, PPARGC1A, AKT2, LEP, ADIPOQ
148.9INS, DIO2, DIO3, DIO1, TNF
158.6APOE, PPARGC1A, PPARG, AKT2, INS, PLIN1
168.1ADIPOQ, PPARGC1A, PPARG, RETN, INS, LEP
17
Hide members
8.1TNF, APOE, PPARGC1A, PPARG, AKT2, INS
18
Hide members
7.9TNF, RBP4, AKT2, RETN, INS, LEP

Compounds for genes affiliated with Familial Partial Lipodystrophy

About this section
Sources:
44Novoseek, 28IUPHAR, 11DrugBank, 59Tocris Bioscience, 24HMDB, 49PharmGKB
See all sources

Compounds related to Familial Partial Lipodystrophy according to GeneCards/GeneDecks:

(show top 50)    (show all 107)
idCompoundScoreTop Affiliating Genes
1estrogen4410.7DIO2
2cycloheximide4410.6DIO2
3dehydroepiandrosterone sulfate4410.3RBP4
4fatty acid4410.0PLIN1, RBP4, PPARG
5palmitate4410.0ADIPOQ, INS, PPARGC1A
6glucose449.8DIO2, PPARG, RBP4, PLIN1
7telmisartan44 28 1111.8PPARG, INS, LEP, ADIPOQ
8orlistat44 59 1111.8PPARG, INS, LEP, ADIPOQ
9norepinephrine44 11 2411.7PLIN1, RETN, PPARGC1A
10glycerol 3-phosphate44 2410.7PPARG, LEP, PLIN1, ADIPOQ
11bezafibrate44 28 1111.7ADIPOQ, INS, PPARG, APOE
12stavudine44 1110.7PPARG, LEP, ADIPOQ
13ritonavir44 49 1111.6APOE, PPARG, INS, ADIPOQ
14aicar44 11 2411.5PPARGC1A, PPARG, INS, LEP, ADIPOQ
15sibutramine44 1110.5INS, LEP, ADIPOQ
16glimepiride44 49 1111.5PPARG, RETN, INS, ADIPOQ
17olanzapine49 44 28 11 2413.4ADIPOQ, LEP, INS, APOE
18glibenclamide44 28 49 5912.4APOE, INS, LEP, ADIPOQ
19troglitazone44 28 59 1112.3TNF, PPARG, INS, LEP, ADIPOQ
20glycerol44 11 2411.3PPARG, INS, LEP, PLIN1, ADIPOQ
21thiazolidinedione449.2PPARG, RETN, INS, LEP, ADIPOQ
22prostacyclin449.1TNF, APOE, PPARG, LEP, ADIPOQ
23ciglitazone44 2810.1TNF, APOE, PPARG, RARB
24simvastatin44 49 59 28 11 2414.0TNF, APOE, PPARG, RBP4, ADIPOQ
25rapamycin449.0APOE, PPARG, AKT2, INS, LEP, ADIPOQ
26nash449.0TNF, RETN, INS, LEP, ADIPOQ
278-isoprostane449.0TNF, RETN, INS, LEP, ADIPOQ
28ibmx44 28 5911.0APOE, PPARG, INS, PLIN1, RARB
29atorvastatin44 49 28 11 2413.0ADIPOQ, RETN, PPARG, APOE, TNF
30triiodothyronine448.9DIO1, DIO3, DIO2, RBP4, LEP, SLC16A2
31metformin44 49 1110.9PPARGC1A, PPARG, RETN, INS, LEP, ADIPOQ
32sterol448.9APOE, PPARGC1A, PPARG, EMD, RETN, ADIPOQ
33fenofibrate44 49 1110.8TNF, PPARG, RETN, INS, LEP, ADIPOQ
34triacylglycerol448.8APOE, PPARGC1A, RBP4, INS, LEP, PLIN1
35c-peptide448.7RETN, INS, LEP, ADIPOQ
36betacarotene448.6RARB, LEP, RBP4, APOE
37ly294002448.5TNF, PPARG, AKT2, RETN, INS, LEP
38pioglitazone44 49 28 1111.4TNF, PPARG, RBP4, RETN, INS, LEP
39rosiglitazone44 49 28 11 2412.3RARB, LMNA, LEP, INS, RETN, RBP4
40creatinine448.2CAPN3, APOE, RBP4, RETN, INS, LEP
41vitamin a44 11 2410.0APOE, RBP4, RETN, LEP, RARB, ADIPOQ
42cholesterol44 28 11 2410.8APOE, PPARGC1A, PPARG, RBP4, RETN, INS
43retinoic acid44 248.8TNF, DIO2, PPARGC1A, PPARG, RBP4, LMNA
44alanine447.7APOE, DIO3, DIO2, PPARG, RBP4, RETN
45dexamethasone44 49 28 1110.7DIO3, DIO2, RBP4, RETN, INS, RARB
46serine447.7TNF, APOE, DIO2, PPARGC1A, RBP4, AKT2
47testosterone44 59 11 2410.3APOE, PPARGC1A, PPARG, RBP4, RETN, INS
48thyroxine44 248.2APOE, DIO1, DIO3, DIO2, PPARG, RBP4
49cysteine447.1CAPN3, APOE, DIO1, DIO3, DIO2, RBP4
50lipid446.3TNF, APOE, PPARGC1A, PPARG, RBP4, AKT2

GO Terms for genes affiliated with Familial Partial Lipodystrophy

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Familial Partial Lipodystrophy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:0055767.8APOE, RBP4, RETN, INS, LEP, ADIPOQ
2extracellular spaceGO:0056157.5ADIPOQ, TNF, APOE, RBP4, RETN, INS

Biological processes related to Familial Partial Lipodystrophy according to GeneCards/GeneDecks:

(show all 34)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of fatty acid oxidationGO:04632110.4PPARG, PPARGC1A
2negative regulation of acute inflammatory responseGO:00267410.3PPARG, INS
3response to muscle activityGO:01485010.3CAPN3, PPARGC1A
4positive regulation of insulin receptor signaling pathwayGO:04662810.2INS, LEP
5negative regulation of gluconeogenesisGO:04572110.2INS, ADIPOQ
6response to dietary excessGO:00202110.1APOE, LEP
7regulation of I-kappaB kinase/NF-kappaB cascadeGO:04312210.1CAPN3, TNF
8fatty acid oxidationGO:01939510.1PPARGC1A, PPARG, ADIPOQ
9mitotic nuclear envelope reassemblyGO:00708410.1BANF1, EMD, LMNA
10brown fat cell differentiationGO:05087310.1ADIPOQ, PPARG, PPARGC1A
11mitotic nuclear envelope disassemblyGO:00707710.1BANF1, EMD, LMNA
12muscle organ developmentGO:00751710.0CAPN3, EMD, LMNA
13positive regulation of cholesterol effluxGO:01087510.0ADIPOQ, APOE
14cellular response to insulin stimulusGO:03286910.0PPARG, AKT2, ADIPOQ
15leukocyte tethering or rollingGO:05090110.0LEP, TNF
16positive regulation of cellular protein metabolic processGO:03227010.0INS, ADIPOQ
17positive regulation of glucose importGO:04632610.0ADIPOQ, INS, AKT2
18positive regulation of sequence-specific DNA binding transcription factor activityGO:0510919.9PPARG, PPARGC1A, TNF
19hormone biosynthetic processGO:0424469.9DIO2, DIO3, DIO1
20thyroid hormone generationGO:0065909.9DIO1, DIO3, DIO2
21positive regulation of nitric-oxide synthase activityGO:0510009.9APOE, INS
22negative regulation of macrophage derived foam cell differentiationGO:0107459.9PPARG, ADIPOQ
23response to retinoic acidGO:0325269.8APOE, PPARG, RBP4
24negative regulation of lipid catabolic processGO:0509959.8INS, TNF
25positive regulation of membrane protein ectodomain proteolysisGO:0510449.8TNF, APOE
26regulation of insulin secretionGO:0507969.8TNF, INS, LEP
27negative regulation of cartilage developmentGO:0610379.7LEP, RARB
28positive regulation of protein phosphorylationGO:0019349.6TNF, AKT2, ADIPOQ
29positive regulation of glycogen biosynthetic processGO:0457259.6INS, AKT2
30glucose homeostasisGO:0425939.6PPARG, RBP4, INS, ADIPOQ
31response to ethanolGO:0454719.6APOE, RBP4, ADIPOQ
32response to hypoxiaGO:0016669.6ADIPOQ, LEP, PPARGC1A, TNF
33glucose metabolic processGO:0060069.3ADIPOQ, LEP, INS, AKT2, TNF
34response to insulin stimulusGO:0328689.2APOE, RBP4, RETN, LEP

Molecular functions related to Familial Partial Lipodystrophy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1selenium bindingGO:00843010.0DIO2, DIO1
2thyroxine 5-deiodinase activityGO:0048009.5DIO2, DIO3, DIO1
3hormone activityGO:0051798.9RETN, INS, LEP, ADIPOQ
4protein bindingGO:0055155.8CAPN3, TNF, APOE, PPARGC1A, PPARG, RBP4

Products for genes affiliated with Familial Partial Lipodystrophy

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Familial Partial Lipodystrophy

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet